Last reviewed: May 23, 2026

Last updated: May 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, pinching skin during GLP-1 subcutaneous injections is the standard recommended technique to create adequate tissue depth for proper medication delivery. Subcutaneous injections require needle penetration into the fatty layer beneath the dermis, typically 5–8 mm deep, which pinching ensures.

Proper injection technique is foundational to treatment success and patient adherence. PlexusDx takes a precision-wellness approach: understanding correct administration, combined with biomarker and genetic context, helps guide more personalized conversations with providers about which GLP-1 formulation and dosing strategy may be most appropriate.

Why Skin Pinching Matters in Subcutaneous GLP-1 Administration

Pinching skin elevates the subcutaneous tissue and reduces variability in needle depth, ensuring medication deposits in the correct anatomical layer. This technique minimizes risk of intramuscular or intradermal injection, which could alter absorption rate and clinical outcomes.

GLP-1 medications like semaglutide and tirzepatide are designed for slow, steady subcutaneous absorption. Improper injection depth can lead to faster absorption, variable efficacy, or increased injection site reactions. Consistent technique supports consistent medication delivery.

Ideal Injection Sites and Rotation Strategy for GLP-1 Therapy

Multiple injection sites reduce lipohypertrophy (fatty lumps) and ensure consistent absorption across treatment duration. Approved and evidence-supported sites include the abdomen, thigh, and upper arm—all have adequate subcutaneous tissue for proper depot formation.

Injection Site Advantages Considerations
Abdomen (2 inches from navel) Large surface area, easy self-access, consistent absorption Avoid previous injection marks by 1 inch; rotate quadrants
Anterior Thigh Accessible, stable tissue depth, good for rotation Less fatty tissue than abdomen in some patients; requires reach
Upper Arm (back of triceps) Easy for caregiver administration, less visible Thinner subcutaneous layer; requires careful depth assessment
Site Rotation Schedule Recommended weekly or per injection frequency Prevents lipohypertrophy, maintains consistent pharmacokinetics over months

Step-by-Step Proper Injection Technique and Safety Precautions

Cleanse the injection site with alcohol for 30 seconds and allow it to air dry completely. Pinch a 1- to 2-inch fold of skin between thumb and forefinger, creating firm elevation without causing pain. Insert the needle at a 45- to 90-degree angle, depending on patient body composition and clinician guidance.

After needle insertion, release the pinched skin and slowly inject the medication over 3–5 seconds. Withdraw the needle at the same angle of entry. Do not reuse needles; use a fresh sterile needle for each injection. Apply light pressure with a clean gauze pad if minor bleeding occurs; do not massage the site.

Individual Variation: When Biomarkers and Genetics Inform Injection Strategy

Subcutaneous tissue composition, injection-site metabolism, and medication absorption rates vary among individuals based on genetic and metabolic factors. Patients with different body compositions may require slight technique adjustments to ensure consistent medication delivery and therapeutic response.

Understanding genetic predispositions in GLP-1 receptor pathways and metabolic markers can help providers tailor both the medication formulation and patient education around injection technique. Personalized guidance ensures adherence and optimizes outcomes over the treatment course.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context around individual variation in GLP-1 receptor expression and metabolic response pathways. While injection technique is universal, genetic insights into GIPR rs1800437 and GLP1R rs6923761 variants can support a more informed conversation with your provider about which GLP-1 formulation and dosing approach aligns with your genetic predispositions.

The genetic test reveals predispositions in peptide metabolism and receptor sensitivity, not exact medication response or injection technique needs. These insights should be interpreted with a qualified healthcare provider to determine if compounded semaglutide, tirzepatide, or other precision-dosed GLP-1 options may be most appropriate for your clinical context.

Combining proper injection technique with biomarker and genetic assessment creates a comprehensive foundation for treatment success. This precision-wellness approach allows patients and providers to make more confident, personalized decisions about GLP-1 therapy initiation and ongoing management.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves